CMHDF (China Resources Medical Holdings Co) YoY EBITDA Growth: 8.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CMHDF China Resources Medical Holdings Co Ltd CMHDF
91 GF Score
Price $0.58
GF Value $0.89
! 5 Warning Signs
View Full Analysis

What is China Resources Medical Holdings Co YoY EBITDA Growth?

China Resources Medical Holdings Co CMHDF 91 YoY EBITDA Growth is 8.00% as of Dec. 2025. GuruFocus rates CMHDF with a GF Score™ of 91/100 and a GF Value™ of $0.89. The stock has 5 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. China Resources Medical Holdings Co's YoY EBITDA Growth for the quarter that ended in Dec. 2025 was 8.00%.

China Resources Medical Holdings Co's EBITDA per Share for the six months ended in Dec. 2025 was $0.03.

China Resources Medical Holdings Co YoY EBITDA Growth Related Terms

China Resources Medical Holdings Co YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for China Resources Medical Holdings Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Resources Medical Holdings Co YoY EBITDA Growth Chart

China Resources Medical Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.43 89.66 22.73 22.22 -7.27

China Resources Medical Holdings Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -152.94 -3.95 377.78 -19.18 8.00
CMHDF
91GF Score
China Resources Medical Holdings Co Ltd CMHDF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Resources Medical Holdings Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

China Resources Medical Holdings Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.153-0.165)/ | 0.165 |
=-7.27 %

China Resources Medical Holdings Co's YoY EBITDA Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (Q: Dec. 2025 )
=(EBITDA per Share (Q: Dec. 2025 )-EBITDA per Share (Q: Dec. 2024 )) / | EBITDA per Share (Q: Dec. 2024 )) |
=(0.027-0.025)/ | 0.025 |
=8.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 8.00% mean?
China Resources Medical Holdings Co (CMHDF) has a YoY EBITDA Growth of 8.00% as of Dec. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for China Resources Medical Holdings Co and its competitors.
Is China Resources Medical Holdings Co's YoY EBITDA Growth too high?
China Resources Medical Holdings Co's current YoY EBITDA Growth is 8.00%. Overall, China Resources Medical Holdings Co has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does China Resources Medical Holdings Co's YoY EBITDA Growth compare to HCA and THC?
China Resources Medical Holdings Co's YoY EBITDA Growth of 8.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for China Resources Medical Holdings Co and its competitors. China Resources Medical Holdings Co's current YoY EBITDA Growth is 8.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Medical Holdings Co stock overvalued right now?
China Resources Medical Holdings Co (CMHDF) has a current YoY EBITDA Growth of 8.00%. The stock's GF Value™ is $0.89, compared to a current price of $0.58 — trading 34.8% below its estimated fair value. The current YoY EBITDA Growth is 8.00%. China Resources Medical Holdings Co's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For China Resources Medical Holdings Co (CMHDF), the current YoY EBITDA Growth is 8.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Resources Medical Holdings Co (CMHDF) Overvalued in 2026?

Based on GuruFocus' analysis, China Resources Medical Holdings Co stock appears to be undervalued. The current stock price of $0.58 is trading 34.8% below its estimated GF Value™ of $0.89.

Key valuation signals for CMHDF:

  • YoY EBITDA Growth: 8.00%
  • GF Value™: $0.89 vs. price of $0.58 (34.8% below fair value)
  • GF Score™: 91/100 with 5 warning signs

No single metric tells the full story. See the CMHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Resources Medical Holdings Co Business Description

Other Exchanges 01515:Hong Kong1PH:Germany
Address No. 9, Fuyi Street, 14th Floor, Kunlun Center Office Building, Fengtai District, Beijing, CHN, 100069
China Resources Medical Holdings Co Ltd is engaged in the provision of general healthcare services; provision of hospital management services, sale of pharmaceuticals, medical devices, and medical consumables, and provision of other services in the Chinese Mainland. The group has two operating segments: Hospital Business and Other Business. The Hospital Business segment includes outpatient business and inpatient business corresponding to self-owned hospitals. The Other business segment includes operation management services, supply chain services, and other ancillary services provided to participating hospitals and IOT/OT hospitals. It generates the majority of its revenue from the Hospital Business segment.
91GF Score

Get the complete analysis for CMHDF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.58
Price
$0.89
GF Value